Rheumatoid Factor Beyond Rheumatoid Arthritis: Metabolic and Immunologic Implications in Diabetes Mellitus
Mugo Moses H.
School of Natural and Applied Sciences Kampala International University Uganda
ABSTRACT
Rheumatoid factor (RF), a classic autoantibody directed against the Fc portion of immunoglobulin G (IgG), has long been recognized as a hallmark of rheumatoid arthritis (RA). However, emerging evidence indicates that RF positivity extends far beyond rheumatologic disease and may carry important metabolic and immunologic implications, particularly in diabetes mellitus. The rising global burden of diabetes, including both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), has renewed interest in the role of chronic inflammation and autoimmunity in metabolic dysregulation. RF has been detected in a substantial proportion of diabetic individuals, especially those with long-standing hyperglycemia, microvascular complications, or coexisting autoimmune phenomena. Its presence correlates with oxidative stress, subclinical inflammation, endothelial dysfunction, and altered immunometabolic pathways. Recent studies suggest that RF positivity may predict poor glycemic control, increased cardiovascular risk, and enhanced susceptibility to diabetic complications, independent of traditional risk factors. Moreover, RF may reflect broader immune dysregulation involving B-cell hyperactivity, advanced glycation end-products, molecular mimicry, and chronic antigenic stimulation. This review synthesizes current evidence on the epidemiology, mechanisms, clinical significance, and potential therapeutic implications of RF in diabetes, highlighting its emerging role as a biomarker of systemic immune activation beyond rheumatoid arthritis.
Keywords: Rheumatoid factor, Diabetes mellitus, Autoimmunity, Inflammation, Immunometabolism
CITE AS: Mugo Moses H. (2026). Rheumatoid Factor Beyond Rheumatoid Arthritis: Metabolic and Immunologic Implications in Diabetes Mellitus. IAA Journal of Applied Sciences 14(1):6-11.